🇺🇸 FDA
Pipeline program

Forodesine Hydrochloride Sterile Solution, 5 mg/mL

BCX1777-Tio-05-202

Phase 2 small_molecule terminated

Quick answer

Forodesine Hydrochloride Sterile Solution, 5 mg/mL for Leukemia is a Phase 2 program (small_molecule) at BIOCRYST PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
BIOCRYST PHARMACEUTICALS INC
Indication
Leukemia
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials